In the BioHarmony Drug Report Database

"Preview" Icon

Tinzaparin

Innohep (tinzaparin sodium) is an oligosaccharide pharmaceutical. Tinzaparin sodium was first approved as Innohep on 2000-07-14. It is used to treat pulmonary embolism, thromboembolism, and venous thrombosis in the USA. It has been approved in Europe to treat venous thromboembolism. The pharmaceutical is active against antithrombin-III.

 

Trade Name

 

Innohep
 

Common Name

 

tinzaparin sodium
 

ChEMBL ID

 

CHEMBL1201414
 

Indication

 

pulmonary embolism, thromboembolism, venous thromboembolism, venous thrombosis
 

Drug Class

 

Heparin derivatives and low molecular weight (or depolymerized) heparins

Image (chem structure or protein)

Tinzaparin structure rendering